Supernus Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 6 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Fund move
Fund move
No thesis.
Supernus Pharmaceuticals, Inc.
41.94
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $434.9M | 15.48% | +6.28% | |
| 2 | Millennium ManagementMillennium | $179.2M | 6.38% | +16.20% | |
| 3 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $153.7M | 5.47% | +2.06% | |
| 4 | Armistice CapitalArmistice Capital | $123.1M | 4.38% | +39.62% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $117.1M | 4.17% | +2.01% | |
| 6 | State StreetState Streetindex-like | $114.4M | 4.07% | +7.50% | |
| 7 | Delaware Management HoldingsDelaware | $110.6M | 3.94% | +16.74% | |
| 8 | Dimensional Fund AdvisorsDimensional | $96.7M | 3.44% | −9.92% | |
| 9 | Geode Capital ManagementGeodeindex-like | $73.0M | 2.60% | −3.29% | |
| 10 | Stephens Investment Management GroupStephens | $69.1M | 2.46% | +9.95% | |
| 11 | Renaissance TechnologiesRenaissance Technologies | $68.8M | 2.45% | −13.31% | |
| 12 | Loomis Sayles & Co L PLoomis Sayles & Co L P | $68.6M | 2.44% | +3.47% | |
| 13 | Citadel AdvisorsCitadel | $66.0M | 2.35% | −7.10% | |
| 14 | Two Sigma InvestmentsTwo Sigma | $55.1M | 1.96% | +336.67% | |
| 15 | GW&K Investment ManagementGW&K | $48.2M | 1.72% | −1.70% | |
| 16 | Sofinnova InvestmentsSofinnova | $48.2M | 1.72% | +8.59% | |
| 17 | Qube Research & TechnologiesQube Research & Technologies | $42.9M | 1.53% | +85.10% | |
| 18 | Morgan StanleyMorgan Stanley | $40.8M | 1.45% | −4.05% | |
| 19 | Goldman Sachs GroupGoldman Sachs | $38.1M | 1.36% | −4.33% | |
| 20 | D. E. ShawD. E. Shaw | $35.7M | 1.27% | +23.33% | |
| 21 | Northern TrustNorthern Trustindex-like | $34.1M | 1.21% | +4.85% | |
| 22 | Woodline PartnersWoodline Partners | $32.9M | 1.17% | +57.75% | |
| 23 | Charles Schwab Investment ManagementCharles Schwabindex-like | $32.7M | 1.16% | −0.34% | |
| 24 | Bank of AmericaBank of America | $28.9M | 1.03% | −13.04% | |
| 25 | Ashford Capital ManagementAshford | $28.5M | 1.02% | −4.90% |
334 managers report $2.8B of Supernus Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 30 of them hold 80% of it; BlackRock is largest at 15.48%.
Linked news
Expected move
No implied move.
No implied move.
No implied move.